REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 433 filers reported holding REPLIGEN CORP in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $60,661,175 | +11.4% | 381,493 | -0.9% | 0.89% | +20.6% |
Q2 2023 | $54,472,800 | +267.6% | 385,076 | +337.5% | 0.74% | +252.6% |
Q1 2023 | $14,817,680 | +8.2% | 88,012 | +8.8% | 0.21% | +2.0% |
Q4 2022 | $13,698,703 | -12.6% | 80,909 | -3.4% | 0.20% | -15.3% |
Q3 2022 | $15,665,000 | -0.6% | 83,723 | -13.8% | 0.24% | +9.0% |
Q2 2022 | $15,766,000 | -6.2% | 97,079 | +8.6% | 0.22% | +14.4% |
Q1 2022 | $16,809,000 | +3.5% | 89,368 | +45.8% | 0.19% | +19.0% |
Q4 2021 | $16,237,000 | -9.1% | 61,309 | -0.8% | 0.16% | -10.9% |
Q3 2021 | $17,860,000 | +55.0% | 61,801 | +7.1% | 0.18% | +50.0% |
Q2 2021 | $11,523,000 | +9.7% | 57,726 | +6.9% | 0.12% | 0.0% |
Q1 2021 | $10,503,000 | +9.7% | 54,023 | +8.1% | 0.12% | +9.9% |
Q4 2020 | $9,575,000 | +42.3% | 49,965 | +9.5% | 0.11% | +22.0% |
Q3 2020 | $6,730,000 | +22.9% | 45,612 | +3.0% | 0.09% | +9.6% |
Q2 2020 | $5,476,000 | +103.7% | 44,300 | +59.1% | 0.08% | +59.6% |
Q1 2020 | $2,688,000 | – | 27,848 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |